What is mass spectrometry for peptide identity?
Mass spectrometry confirms peptide identity by ionising the sample, separating the resulting ions by mass-to-charge ratio, and comparing the observed mass to the theoretical mass calculated from the peptide’s sequence. Agreement within the instrument’s mass-accuracy specification confirms identity. Mass spectrometry is the standard identity check that pairs with HPLC purity quantitation on a credible peptide COA.
What the research literature says
Mass spectrometry (MS) is an analytical technique with three core architectural components: an ion source that converts neutral sample molecules into gas-phase ions, a mass analyser that separates the ions by mass-to-charge ratio (m/z), and a detector that measures ion abundance at each m/z. The output spectrum encodes the molecular masses of the species present in the sample.
For peptide identity verification, the dominant ionisation modes are electrospray ionisation (ESI — gentle ionisation preserving peptide structure, producing multiply-charged ions) and matrix-assisted laser desorption/ionisation (MALDI — producing predominantly singly-charged ions). The dominant mass analysers in peptide-supply QC are quadrupole, time-of-flight (TOF), and Orbitrap instruments, with TOF and Orbitrap providing the higher resolution and mass accuracy needed to distinguish a target peptide from close-mass isobars.
The verification logic: calculate the theoretical mass of the target peptide from its sequence (sum of amino-acid residue masses plus water mass for the peptide bond hydrolysis correction); inject sample, acquire mass spectrum, identify the dominant peak; compare observed mass against theoretical mass; agreement within the instrument’s mass-accuracy specification confirms identity. The USP <1736> general chapter covers mass-spectrometric methods in pharmaceutical analysis.
Why this matters in research context
HPLC purity answers “how much of the sample is the target peak”; mass spectrometry answers “is the target peak actually the intended peptide”. Both are required for a complete identity-and-quality verification — HPLC alone cannot distinguish two peptides with similar HPLC retention but different sequences; mass spectrometry alone doesn’t tell you what fraction of the sample is the target. The credible peptide COA pairs both methods on the same batch.
Related compounds
- Mass spectrometry (glossary entry) — analytical methodology
- Certificate of analysis (glossary entry) — COA framework
Related research questions
References
- ICH Q2(R1) — Validation of Analytical Procedures: Text and Methodology. International Council for Harmonisation.
- USP <1736> Applications of Mass Spectrometry. General chapter on mass-spectrometric methods in pharmaceutical analysis. United States Pharmacopeia.
- USP <621> Chromatography. General chapter that complements the mass-spectrometric identity check by defining the chromatographic purity-quantitation framework. United States Pharmacopeia.
Research-questions pages describe research-context use of peptide-research terminology. They do not constitute medical, veterinary, or clinical advice. Every compound in the Ronin catalog is sold strictly for laboratory and research use only.